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Pendred syndrome is an autosomal recessive disor­
der characterized by goiter and congenital deafness. 
The primary defect is not yet known, although the 
gene causing Pendred syndrome has been localized 
very recently on chromosome 7q, a region that also 
contains a gene responsible for nonsyndromal hearing 
loss (DFNB4). We confirmed linkage to this chromo­
some 7 region in  five Pendred families originating 
from different ethnic groups, w ith a highest cumula­
tive lod score of 8.26 for marker D7S501, In  combina­
tion w ith previous reports, our results define a candi­
date region for the Pendred gene of 1.7 cM flanked by 
markers D7S5G1 and D7S692. © 1997 A cad e m ic  Press
IN T R O D U C T IO N
Pendred syndrome (MIM No. 274600) is character­
ized by the presence of goiter and profound congenital 
sensorineural hearing loss (Pendred, 1896). Most af­
fected persons are euthyroid, although hypothyroidism 
is occasionally reported (Batsakis <?£ al., 1962), Hearing 
impairment is usually congenital and, in nearly all 
cases, is accompanied by a type of cochlear hypoplasia 
known as a Mondini defect (Gorlin, 1995). The disease 
prevalence of Pendred syndrome is estimated at 4-10%  
among congenitally deaf children, and the frequency 
varies from 1/15,000 in the British Isles to 1/100,000 
in Scandinavia (Gorlin, 1995).
Inheritance is generally considered to be autosomal 
recessive, and in many families, consanguinity between 
nonaffected parents can be documented. However, 
there are some families in which the disease apparently 
skips generations, and the phenotype varies in affected 
persons. These intrafamilial differences are consistent
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with autosomal dominant inheritance with incomplete 
penetrance (Ilium et al., 1972).
The primary defect responsible for Pendred syn­
drome is not yet known, although it probably involves 
the partial failure to convert free iodide into organic 
iodine in the thyroid gland in Pendred patients (Frazer, 
1965; Morgans and Trotter, 1958). The latter process 
is a complex sequence of metabolic events. During the 
formation of thyroid hormones, iodide is first oxidized 
and then covalently bound to thyroglobulin (TG) to 
form iodotyrosyls by thyroperoxidase (TPO), The iodo- 
tyrosyls are subsequently coupled oxidatively into iodo- 
thyronines T3 and T4 within the matrix of TG (Dumont 
et a l ,  1994). The iodine organification defect in Pen­
dred patients is demonstrated with the perchlorate 
test, which releases free iodine from the thyroid gland 
and is very common in patients with Pendred syndrome 
(Ilium et al., 1972). TG and TPO are both major compo­
nents of the iodine organification system. However, bio­
chemical studies failed to find abnormalities in these 
proteins in Pendred patients (Burrow et ah, 1973; Mang- 
klabruks et a l ,  1991; Ljunggren et a l 1973; Niepom- 
niszeze et aL, 1978; Cave and Dunn, 1975), and genetic 
linkage analysis excluded both genes (Coucke et al ., 
1995; Coyle et aL, 1996).
Recently, two groups reported linkage of Pendred 
syndrome to chromosome 7q31 in an interval of 5.5 and 
9.2 cM, respectively (Coyle et al., 1996; Sheffield et al.,
1996). In the present study, we confirm the localization 
of the Pendred syndrome gene to 7q31, provide more 
evidence for genetic homogeneity, and reduce the can­
didate region to 1.7 cM.
MATERIALS AND METHODS
Families. The diagnosis of Pendred syndrome was established 
when individuals presented congenital hearing loss and a palpable 
goiter. In all five families an abnormal perchlorate test was present 
in at least one family member. Family 1 originates from Belgium
0888-7543/97 $25.00
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and is not consanguineous (Fig 1). Family 2 originates from an iso­
lated small village, Tasobasi, in the South of Turkey. This family is 
highly consanguineous and includes more then 13 affected individu­
als (Fig. 1). The family has been subject of a previous clinical study 
(Kabakkaya et at, 1993). Families 3 and 4 originate from the Nether­
lands, and the parents of the patients are consanguineous. The two 
patients from Family 4 have been described extensively (Cremers, 
1976). A fifth family lives in Denmark but originates from Lebanon, 
Patient IV-2 from this family showed no goiter and a normal perchlo­
rate test, although congenital hearing loss was present, and a co­
chlear defect of the Mondini type was shown by CT scan. Patient IV-
3 has congenital hearing loss, a Mondini malformation of the cochlea, 
an abnormal perchlorate test, but no goiter.
Linkage analysis. Genomic DNA was purified from peripheral 
blood samples by standard techniques. Microsatellite polymorphisms 
were taken from the recent genetic map from Genethon (Dib et a i,
1996), Polymerase chain reaction amplification and electrophoresis 
on polyacrylamide gels were performed as described (Hughes, 1993). 
Two-point linkage analysis was performed using the MLINK pro­
gram of the LINKAGE 5.1 package (Lathrop and Laouel, 1984). An 
estimated frequency of 1/100 was used for the disease gene, and 
penetrance was set at 100%. Allele frequencies were set equal to each 
other. Lod score calculations in Family 2 were performed without 
the consanguinity of the parents of sibship B and of the paternal 
grandparents of sibship D taken into account.
RESULTS
Linkage Analysis
Five families segregating with Pendred syndrome 
were studied (Fig. 1). We typed these five pedigrees 
with 10 polymorphic markers from 7q31. All these 
markers were obtained from the most recent Genethon 
genetic map (Fig. 2) (Dib et al., 1996). Table 1 summa­
rizes the two-point lod scores for the 10 markers. Cu­
mulative lod scores higher than 3 were obtained for 
all markers except D7S523. The highest combined lod 
score of 8.26 was obtained for marker D7S501 at recom­
bination fraction 0. When the lod scores for each of the 
families were analyzed separately, lod scores higher 
than 3 were obtained only for Family 2 with a maxi­
mum of 4.91 for marker D7S496 at recombination frac­
tion 0. The other four families are too small to yield 
statistically significant lod scores, but the theoretical 
maximum lod score was approached for each of the 
families when the lod scores were calculated with 100% 
informative markers. Therefore, it is likely that all five 
families are linked to chromosome 7q. Statistical analy­
sis of the data using HOMOG (Ott, 1991) gave a maxi­
mum likelihood under the hypothesis of linkage homo­
geneity, confirming this assumption.
Uaplotype Analysis
To narrow down the candidate region of the Pendred 
gene, haplotypes were constructed for the 10 markers 
that were analyzed. As Family 2 is highly inbred, ho­
mozygosity mapping was used to delineate the interval 
containing the Pendred gene. In this family, eight .Pen­
dred patients from four related sibships (A-D) were 
analyzed (Fig. 1). In sibship A, the parents are first 
cousins, and both patients are homozygous for all 10
markers tested. The parents for sibship B were re­
ported to be consanguineous, but the exact nature of 
their blood relationship could not be indicated by the 
family members. The three patients from sibship B are 
homozygous for four adjacent markers, D7S2453, 
D7S501, D7S496, and D7S2459. In contradiction to the 
consanguinity of the parents of sibship C that was re­
ported in a previous study (Kabakkaya et a i , 1993), 
extensive interviews of the family on several occasions 
in the course of this study revealed no reports of con­
sanguinity between the parents of sibship C. As the 
father of this sibship has a completely different disease 
haplotype, he is most likely unrelated to the family and 
carries an independent Pendred mutation. The parents 
of sibship D are first cousins, and the paternal grand­
parents were also reported to be related by family mem­
bers, although they could not indicate the exact nature 
of this consanguinity. The patient from sibship D is 
homozygous for five adjacent markers, D7S2453, 
D7S501, D7S496, D7S2459, and D7S692. When the
disease-carrying chromosome from the unrelated fa­
ther of sibship C is not taken into account, all the haplo­
types of the eight patients in Family 2 are i dentical for 
the four adjacent markers D7S2453, D7S501, D7S496, 
and D7S2459. Under the assumption that the parents 
of sibship B are consanguineous and have inherited the 
same mutation from a common ancestor, a historical 
recombination must have occurred between the Pen­
dred gene and D7S692. This assumption is likely for 
two reasons. First, several family members confirmed 
the consanguinity of the parents of sibship B. Second, 
the three patients of sibship B are homozygous for four
adjacent markers, D7S2453, D7S501, D7S496, and 
D7S2459, that also show several other alleles in the 
rest of the family. For these reasons, it is more likely 
that those four adjacent markers are homozygous by 
descent than that they are homozygous by chance. Un­
der the more likely hypothesis of a single common an­
cestral disease chromosome, this key recombinant de­
fines the candidate region for the Pendred gene as an 
interval of 6.9 cM flanked by D7S2446 and D7S692 
(Fig. 2).
Haplotype analysis of Families 1, 3, and 4 confirms 
the candidate region determined in Family 2. A recom­
bination between D7S2446 and the Pendred gene in 
patient II-l from Family 1 confirms the exclusion of 
the region centromeric to D7S2446, whereas recombi­
nations with D7S523 in Families 3 and 4 confirm that 
the Pendred gene is located centromeric to D7S523 
(Figs. 1 and 2).
DISCUSSION
4
In this study we confirm the localization of the Pen­
dred gene to chromosome 7q31 by linkage analysis and 
homozygosity mapping in five families with Pendred 
syndrome. The highly consanguineous Family 2, origi­
nating from Turkey, contains at least 13 Pendred pa-
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FIG. 2 . Linkage map of the markers used in the analysis. The 
genetic distances between the markers are indicated in centi- 
morgans. The candidate region for Pendred syndrome is indicated 
by the bold line.
tients and is therefore very useful for linkage analysis, 
yielding lod scores higher than 3 with chromosome 7 
markers. The other four families, of which three are 
consanguineous, are much smaller. However, they are 
probably also linked to this region based upon the ho­
mozygosity in the patients of the consanguineous Fam­
ilies 3, 4 and 5 and the positive lod score of 0.98 for 
Family 1.
Combining previously reported data (Coyle et al., 
1996; Sheffield et ah, 1996) with our own data, we could 
narrow the candidate region to 1.7 cM between mark­
ers D7S501 and D7S692. However, it should be noted
Lebanon. Coyle et al. (1996) reported linkage in 11 fam­
ilies of British origin and 1 from Asia, and Sheffield et 
al. (1996) proved linkage in 2 families of Arab origin. 
There is no indication for genetic heterogeneity in any 
of these 19 families, although most of these families 
are too small to prove linkage independently. These 
results suggest that the locus on chromosome 7q may 
be the only locus for Pendred syndrome. Because only 
a limited number of families have been analyzed so far, 
additional linkage studies should be performed to prove 
genetic homogeneity. This is important if genetic diag­
nosis is requested by small families affected with the 
disease.
Three other hereditary diseases have been mapped 
to the Pendred chromosomal region: nonsyndromal au­
tosomal recessive deafness DFNB4 (Baldwin et al.,
1995), cystic fibrosis (CF) (Riordan et al.} 1989), and 
congenital chloride diarrhea (CLD) (Kere et ah, 1993). 
The candidate regions for DFNB4 and CLD are identi­
cal and are bounded by flanking markers D7S501 and 
D7S523. Both markers were mapped a few centi- 
morgans proximal to the CF gene (Kere et a l , 1993). 
This means that the Pendred candidate region deter­
mined in this study is entirely located inside the candi­
date region of DFNB4 and CLD. To our knowledge, 
no genes with a known function in hearing or thyroid 
metabolism have been mapped to this region, which 
would make them obvious candidate genes for Pendred 
syndrome. Although CLD and Pendred syndrome prob­
ably map to the same region by chance, the colocaliza­
tion of DFNB4 and Pendred syndrome might not be 
coincidental. It has been shown that a single gene can 
be responsible for both syndromic and nonsyndromic 
deafness, as mutations in the myosin VILA gene give 
rise to Usher syndrome (Weil et a l 3 1995) as well as 
nonsyndromal deafness (DFNB2) (Ayadi et al., 1996). 
As no perchlorate test was performed in the DFNB4 
family, and the size of the goiter is variable in Pendred 
syndrome, thyroid problems might have remained un­
detected in the DFNB4 family. Alternatively, it is possi­
ble that certain mutations in the same gene lead to a 
combined defect of iodine organification and deafness, 
while other mutations lead only to deafness. On the 
other hand only one of the three patients from Family 
5 had all typical abnormalities of Pendred syndrome
that both flanking markers are based on a single recom- (deafness, Mondini malformation, goiter, abnormal
binant. The proximal flanking marker D7S501 recom­
bines with the Pendred gene in a patient from a small 
pedigree, published in a previous study (Coyle et a l ,
1996). The distal flanking marker D7S692, which 
comes from the analysis of Family 2 (sibship B) in this 
study, is based on the assumption that the parents of 
sibship B are consanguineous and have inherited the 
same mutation from a common ancestor.
Linkage of Pendred syndrome to chromosome 7q31 
has been found now in 19 families from different ethnic 
origins. Our study includes 5 families originating from 
Belgium, The Netherlands (2 families), Turkey, and
perchlorate test), whereas one sibling had no goiter 
and two siblings had a normal perchlorate test. This 
intrafamilial clinical variability shows that the diagno­
sis of Pendred syndrome can be missed and that cases 
might be classified as nonsyndromic deafness.
The relatively small region of 1.7 cM containing the 
Pendred gene will make it possible to use positional 
cloning techniques to isolate the Pendred gene. This 
will be an important step in the elucidation of the mo­
lecular pathology of the syndrome. The gene identifica­
tion will also clarify whether Pendred syndrome and 
DFNB4 are allelic or not and lead to a better under-
TABLE 1
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Two-Point Lod Scores between Pendred Syndrome and Markers Located on Chromosome 7q
Recombination fraction
Marker 0 . 0 0 0 . 0 1 0,05 0 , 1 0 0 . 2 0 0.30 0.40
D7S2446 Family 1 — -3.02 -1.60 -0.99 -0.44 —0.17 -0.04
Family 2 2.91 3.01 2.96 2.61 1.74 0.90 0.28
Family 3 0.82 0.78 0.64 0.47 0 . 2 1 0.07 0 . 0 2
Family 4 1.28 1.24 1.09 0.90 0.56 0.27 0.09
Family 5 1 . 2 0 1.17 1.06 0.91 0.64 0.39 0.17
Total — OC 3.18 4,15 3.90 2.71 1.46 0.52
D7S2453 Family 1 0 . 6 8 0.65 0.53 0,38 0.15 0.03 0 . 0 0
Family 2 4.29 4.18 3.73 3.18 2.08 1 . 1 1 0.39
Family 3 0.70 0.67 0.56 0.43 0.23 0 . 1 0 0.03
Family 4 1.18 1.14 1 . 0 0 0.82 0.50 0.24 0.07
Family 5 1.18 1.15 1.04 0.89 0.62 0.37 0.16
Total 8.03 7.79 6 . 8 6 5,70 3.58 1.85 0.65
D7S501 Family 1 0.98 0,95 0.82 0.67 0.38 0.16 0,03
Family 2 4.19 4.09 3.67 3.14 2 , 1 0 1.17 0.45
Family 3 0.73 0.69 0.56 0.40 0.17 0.06 0 . 0 1
Family 4 1.18 1.14 1 . 0 0 0.82 0.50 0.24 0.07
Family 5 1.18 1.15 1.04 0.89 0.62 0.37 0.16
Total 8.26 8 . 0 2 7.09 5,92 3.77 2 . 0 0 0.72
D7S496 Family 1 0 . 0 0 0 . 0 0 0 . 0 0 0 . 0 0 0 . 0 0 0 . 0 0 0 . 0 0
Family 2 4.91 4.78 4.25 3.60 2.34 1.24 0.44
Family 3 0.65 0.61 0.49 0.34 0.14 0.05 0 . 0 1
Family 4 1 . 1 0 1.06 0.92 0.75 0.45 0 . 2 1 0.07
Family 5 0,78 0.77 0.75 0.69 0.53 0.35 0.16
Total 7.44 7.22 6.41 5.38 3.46 1.85 0 . 6 8
D7S2459 Family 1 0.07 0.07 0.06 0.05 0.03 0 . 0 1 0 . 0 0
Family 2 4.89 4.76 4.25 3.61 2.36 1.26 0.44
Family 3 0,67 0.63 0.50 0.36 0.15 0.05 0 . 0 1
Family 4 1 . 1 0 1.06 0.92 0.75 0.45 0 . 2 1 0.07
Family 5 0.78 0.77 0.75 0.69 0.53 0.35 0.16
Total 7.51 7.29 6.48 5.46 3.52 1 . 8 8 0 . 6 8
D7S692 Family 1 0.07 0.07 0.06 0.05 0.03 0 . 0 1 0 . 0 0
Family 2 3.96 3.87 3.48 2.97 1.93 1 . 0 0 0.33
Family 3 0.48 0.46 0.38 0,29 0.15 0.07 0 . 0 2
Family 4 1 . 1 0 1.06 0.92 0.75 0.45 0 . 2 1 0.07
Family 5 1.05 1 . 0 2 0.90 0.76 0.49 0.26 0.08
Total 6 . 6 6 6.48 5.74 4.82 3.05 1.55 0.50
D7S2425 Family 1 0.98 0.95 0.82 0.67 0.38 0.16 0.03
Family 2 1.13 1.29 1,44 1.33 0.90 0.47 0.14
Family 3 0.65 0.61 0.49 0.34 0.14 0.05 0 . 0 1
Family 4 1 . 0 1 0.98 0.84 0 . 6 8 0.40 0.19 0.06
Family 5 1.14 1 . 1 1 1 . 0 0 0 . 8 6 0.59 0.35 0.15
Total 4.91 4.94 4.59 3.88 2.41 1 . 2 2 0.39
D7S525 Family 1 0.07 0.07 0.06 0.05 0.03 0 . 0 1 0 . 0 0
Family 2
a % _
1.65 1.78 1 . 8 6 1 . 6 8 1.14
V|# 9 VM 
0.61 0 . 2 2
Family 3 0.73 0.69 0,56 0.40 0.17 0.06
w  # A d 
0 . 0 1
Family 4 1,18 1.14 1 . 0 0 0.82 0.50 0.24 0,07
Family 5 0.40 0.39 0.33 0.25 0.14
m Mb
0.05 0 . 0 1
Total 4.03 4.07 3.81 3.20 1.98 0.97 0.31
TABLE 1—Continued.
LOCALIZATION OF PENDRED GENE IN A 1.7-cM REGION ON 7q 53
Marker 0 , 0 0 0 . 0 1
D7S523 Family 1 0.37 0.37
Family 2 1.15 1.30
Family 3 -0.12 -0,11
Family 4 0.06 0,09
Family 5 1.05 1 . 0 2
Total 2.51 2.67
D7S486 Family 1 0.98 0.95
Family 2 1.82 1.94
Family 3 -0.12 - 0.11
Family 4 0.09 0.11
Family 5 1 . 2 1 1.18
Total 3.98 4.07
Recombination fraction
0,05 0 . 1 0 0 . 2 0 0.30 0.40
0.33 0.28 0.19 0.09 0.03
1.45 1.36 0,98 0.55 0 . 2 0
-0.05 -0.02 0 . 0 1 0.00 0.00
0.15 0.18 0.14 0.07 0 . 0 2
0.91 0.77 0.50 0.26 0.08
2.79 2,57 1,82 0.97 0.33
0.82 0.67 0.38 0.16 0.03
2.06 1.93 1,37 0.73 0.24
-0.07 -0.04 0 . 0 1 0 . 0 1 0.00
0.18 0.19 0.15 0.08 0 . 0 2
1.06 0.92 0.64 0.39 0.17
4.05 3.67 2.55 1.37 0.46
standing of inner ear development and thyroid func­
tioning.
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